Claritev (CTEV)
Helps payers manage medical claims costs through networks, analytics, and payment integrity.
$40.00
Pre-market−0.23 (−0.57%)
At close$40.23(+2.24%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 243 | 244 | 235 | 233 | 230 | 232 | 231 | 242 | 246 | 247 | 245 | 257 |
| Cost of revenue | 61 | 61 | 60 | 61 | 61 | 57 | 60 | 61 | 62 | 78 | 180 | 234 |
| Gross profit | 182 | 183 | 174 | 172 | 170 | 175 | 171 | 181 | 184 | 169 | 65 | 23 |
| 142 | 143 | 661 | 696 | 508 | 216 | 161 | 164 | 174 | 160 | 58 | 0 | |
| 37 | 36 | 35 | 35 | 38 | 53 | 51 | 53 | 48 | 48 | 58 | 55 | |
| General & administrative | 37 | 36 | 35 | 35 | 38 | 53 | 51 | 53 | 48 | 48 | 58 | 55 |
| Other expenses | 106 | 107 | 626 | 661 | 470 | 163 | 111 | 111 | 126 | 112 | 0 | −55 |
| Operating income | 40 | 41 | −486 | −524 | −338 | −41 | 10 | 17 | 10 | 9 | 7 | 23 |
| −71 | −73 | −75 | −80 | −80 | −145 | −100 | −100 | −56 | −116 | −99 | −100 | |
| Interest income | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 84 | 83 | 82 | 81 | 82 | 81 | 92 | 100 | 101 | 99 | 98 | 100 |
| Other non-operating income | −14 | −10 | −7 | −1 | −1 | 64 | 8 | 0 | −45 | 16 | 2 | 0 |
| Income before tax | −31 | −32 | −562 | −604 | −419 | −186 | −90 | −83 | −46 | −107 | −93 | −77 |
| Income tax expense | −7 | 0 | −22 | −28 | −27 | −48 | −19 | −20 | 24 | −26 | −19 | −17 |
| Net income from continuing operations | −24 | −31 | −540 | −577 | −391 | −138 | −71 | −63 | −70 | −81 | −74 | −59 |
| Net income | −24 | −31 | −540 | −577 | −391 | −138 | −71 | −63 | −70 | −81 | −74 | −59 |
| EPS, basic | −$1.49 | −$1.95 | −$33.40 | −$35.78 | −$24.25 | −$8.49 | −$4.38 | −$3.81 | −$4.23 | −$4.88 | −$4.41 | −$3.49 |
| EPS, diluted | −$1.49 | −$1.95 | −$33.40 | −$35.78 | −$24.25 | −$8.49 | −$4.38 | −$3.81 | −$4.23 | −$4.88 | −$4.41 | −$3.49 |
| Weighted average shares, basic | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 17 | 17 |
| Weighted average shares, diluted | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 17 | 17 |
| EBITDA | 160 | 159 | −371 | −414 | −227 | 5 | 113 | 129 | 167 | 105 | 117 | 202 |
| Depreciation & amortization | 107 | 108 | 108 | 109 | 110 | 110 | 112 | 112 | 112 | 112 | 112 | 178 |
| EBIT | 53 | 51 | −479 | −523 | −337 | −105 | 2 | 17 | 55 | −8 | 5 | 24 |
